• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

429.11 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5
Open 429.11
Bid (Size) 391.00 (40)
Ask (Size) 442.00 (40)
Prev. Close 429.11
Today's Range 429.11 - 429.11
52wk Range 291.28 - 628.92
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
May 26, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
May 26, 2026
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-24.9%
-24.9%
1 Month
+1.8%
+1.8%
3 Month
-3.0%
-3.0%
6 Month
-29.9%
-29.9%
1 Year
+43.7%
+43.7%

More News

Read More
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 25, 2026
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP
May 24, 2026
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 22, 2026
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
May 19, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 19, 2026
From Schall Law
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 15, 2026
From Schall Law
Via GlobeNewswire
News headline image
Attention Long-Term Shareholders of Hercules Capital Inc. (NYSE: HTGC); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Medpace Holdings, Inc. (NASDAQ: MEDP); and MongoDB Inc. (NASDAQ: MDB): Grabar Law Office Investigates Claims on Your Behalf
May 14, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
2 Reasons to Watch MEDP and 1 to Stay Cautious
May 14, 2026
Via StockStory
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
May 12, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After CEO Allegedly Certified Misleading Statements: Levi & Korsinsky
May 12, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 12, 2026
From Schall Law
Via GlobeNewswire
News headline image
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
May 11, 2026
Via StockStory
News headline image
Important Notice to Long-Term Shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Skyworks Solutions, Inc. (NASDAQ: SWKS); and Upstart Holdings, Inc. (NASDAQ: UPST): Grabar Law Office Investigates Claims
May 11, 2026
From Grabar Law Office
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 08, 2026
From Schall Law
Via GlobeNewswire
News headline image
MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money
May 07, 2026
From Bleichmar Fonti & Auld LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
May 05, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 05, 2026
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
May 04, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
May 01, 2026
From Schall Law
Via GlobeNewswire
News headline image
The 5 Most Interesting Analyst Questions From Medpace’s Q1 Earnings Call
April 29, 2026
Via StockStory
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Medpace Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – MEDP
April 28, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 28, 2026
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Medpace Holdings, Inc. and Encourages Investors to Contact the Firm Before June 5th
April 27, 2026
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Medpace Holdings, Inc. - Common Stock publicly traded?
Yes, Medpace Holdings, Inc. - Common Stock is publicly traded.
What exchange does Medpace Holdings, Inc. - Common Stock trade on?
Medpace Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Medpace Holdings, Inc. - Common Stock?
The ticker symbol for Medpace Holdings, Inc. - Common Stock is MEDP on the Nasdaq Stock Market
What is the current price of Medpace Holdings, Inc. - Common Stock?
The current price of Medpace Holdings, Inc. - Common Stock is 429.11
When was Medpace Holdings, Inc. - Common Stock last traded?
The last trade of Medpace Holdings, Inc. - Common Stock was at 05/26/26 04:00 PM ET
What is the market capitalization of Medpace Holdings, Inc. - Common Stock?
The market capitalization of Medpace Holdings, Inc. - Common Stock is 13.30B
How many shares of Medpace Holdings, Inc. - Common Stock are outstanding?
Medpace Holdings, Inc. - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap